131 related articles for article (PubMed ID: 3257147)
1. Opposite effects of recombinant interferon-alpha A and deoxycoformycin on adenosine deaminase activity in the Daudi B lymphoblastoid cell line.
Faltynek CR
Blood; 1988 Jan; 71(1):59-64. PubMed ID: 3257147
[TBL] [Abstract][Full Text] [Related]
2. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
Ratech H; Kim J; Asofsky R; Thorbecke GJ; Hirschhorn R
J Immunol; 1984 Jun; 132(6):3077-84. PubMed ID: 6202772
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of growth-inhibitory activity of 9-beta-D-arabinofuranosyladenine by 2'-deoxycoformycin in human cultured cell lines derived from leukemias and lymphomas.
Kuroki Y; Shimoyama M; Inaba S; Hirose M
Jpn J Cancer Res; 1989 May; 80(5):482-9. PubMed ID: 2502523
[TBL] [Abstract][Full Text] [Related]
4. Isolation of deoxycoformycin-resistant cells with increased levels of adenosine deaminase.
Hoffee PA; Hunt SW; Chiang J
Somatic Cell Genet; 1982 Jul; 8(4):465-77. PubMed ID: 6981855
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 2'-deoxycoformycin, an inhibitor of adenosine deaminase, in the rat.
Geiger JD; Lewis JL; MacIntyre CJ; Nagy JI
Neuropharmacology; 1987 Sep; 26(9):1383-7. PubMed ID: 3499581
[TBL] [Abstract][Full Text] [Related]
6. Studies on the effect of deoxyadenosine on deoxycoformycin-treated myeloid and lymphoid stem cells.
Aye MT; Dunne JV; Yang WC
Blood; 1982 Oct; 60(4):872-6. PubMed ID: 6981441
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
8. The effects of ADA inhibition on B cell differentiation in the rat.
Barton RW
Adv Exp Med Biol; 1986; 195 Pt A():525-9. PubMed ID: 3524140
[No Abstract] [Full Text] [Related]
9. Specificity of 2'-deoxycoformycin inhibition of adenosine metabolism in intact human skin fibroblasts.
Holland MJ
Res Commun Chem Pathol Pharmacol; 1986 Mar; 51(3):311-24. PubMed ID: 3486439
[TBL] [Abstract][Full Text] [Related]
10. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
Ratech H; Thorbecke GJ; Hirschhorn R
Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339
[No Abstract] [Full Text] [Related]
11. Inhibitor of 2',5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
Biochem Biophys Res Commun; 1985 Mar; 127(3):1019-25. PubMed ID: 3872657
[TBL] [Abstract][Full Text] [Related]
12. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response.
Ho AD; Ganeshaguru K; Knauf W; Dietz G; Trede I; Hoffbrand AV; Hunstein W
Leuk Res; 1989; 13(4):269-78. PubMed ID: 2785618
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxicity of deoxycoformycin: effect of constant infusion on adenosine deaminase, adenosine, 2'-deoxyadenosine and monoamines in the mouse brain.
Helland S; Broch OJ; Ueland PM
Neuropharmacology; 1983 Jul; 22(7):915-7. PubMed ID: 6604884
[TBL] [Abstract][Full Text] [Related]
14. Adenosine deaminase from deoxycoformycin-sensitive and -resistant rat hepatoma cells. Purification and characterization.
Hunt SW; Hoffee PA
J Biol Chem; 1982 Dec; 257(23):14239-44. PubMed ID: 6815190
[TBL] [Abstract][Full Text] [Related]
15. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
Smith CM; Belch A; Henderson JF
Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
[No Abstract] [Full Text] [Related]
16. Energy metabolism in adenosine deaminase-inhibited human erythrocytes.
Buc HA; Thuillier L; Hamet M; Garreau F; Moncion A; Pérignon JL
Clin Chim Acta; 1986 Apr; 156(1):61-9. PubMed ID: 3486057
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of adenosine deaminase leads to enhanced antibody responses in the mouse.
Nicholson JK; Gordon DS; McDougal JS
Cell Immunol; 1983 Jul; 79(2):320-33. PubMed ID: 6347398
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo.
Svendsen KR; Overgaard-Hansen K; Frederiksen S
Cancer Chemother Pharmacol; 1988; 21(1):35-9. PubMed ID: 3257721
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor of 2', 5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
Adv Exp Med Biol; 1986; 195 Pt B():683-7. PubMed ID: 3490130
[No Abstract] [Full Text] [Related]
20. Biochemical changes induced in hairy-cell leukemia following treatment with the adenosine deaminase inhibitor 2'-deoxycoformycin.
Johnston JB; Begleiter A; Pugh L; Leith MK; Wilkins JA; Cavers DJ; Israels LG
Cancer Res; 1986 Apr; 46(4 Pt 2):2179-84. PubMed ID: 2418965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
